Yeun Mi Yim - Concepedia

Author

Yeun Mi Yim

Health Outcomes Solutions (United States)

Also Known As

Y Yim, Y. Yim, Y.M. Yim, Yeun Mi Yim

Publications

587

Citations

H-Index

Concepts

All Affiliations

Health Outcomes Solutions (United States)Saint Louis University Group for Research in Decision Analysis IQVIA (United States)Analysis Group (United States)

About

Yeun Mi Yim is an author at Health Outcomes Solutions (United States) specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	281
2	Public Health	2	2	184
3	Diagnostic Sciences	2	2	51
4	Health Policy	2	2	184
5	Health Sciences	1	1	25

Yeun Mi Yim

Publications

561

Citations

H-Index

Page 1

	Year	Citations
Assessment of costs associated with adverse events in patients with cancer William B. Wong, Yeun Mi Yim, Ashley Kim, PLoS ONE Cancer ManagementEpidemiology Of CancerCancer RegistrationGynecology OncologyAdverse Event	2018	158
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study Charles S. Cleeland, Musa Mayer, Nancy A Dreyer, The Breast	2014	65
Age distribution of patients with advanced non-melanoma skin cancer in the United States Stacey DaCosta Byfield, Diana Chen, Yeun Mi Yim, Archives of Dermatological Research	2013	63
Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology Thomas H. Cartwright, Yeun Mi Yim, Elaine Yu, Clinical Colorectal Cancer Us Community OncologyBevacizumab Beyond ProgressionSurvival OutcomesGastrointestinal OncologyMedicine	2012	39
Differences in Health Care Use and Costs Among Patients With Cancer Receiving Intravenous Chemotherapy in Physician Offices Versus in Hospital Outpatient Settings Maxine D. Fisher, Rajeshwari Punekar, Yeun Mi Yim, Journal of Oncology Practice	2017	30
Assessing Health-Related Quality of Life for Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Susan D. Mathias, Mary‐Margaret Chren, Hilary H. Colwell, JAMA Dermatology	2013	29
Comparative healthcare costs in patients with metastatic melanoma in the USA Chun‐Lan Chang, Vernon F. Schabert, Julie Munakata, Melanoma Research Surgical OncologyCancer ManagementPharmacotherapyDermatologyClinical Epidemiology	2015	26
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study Johan Hansson, Karen Bartley, Thomas Karagiannis, European Journal of Dermatology Health-related QualityCancer ManagementDermatologyLogistic AnalysisOncology	2018	25
Treatment patterns and outcomes in <scp>BRAF</scp> V600E‐mutant melanoma patients with brain metastases receiving vemurafenib in the real‐world setting Geoffrey T. Gibney, Geneviève Gauthier, Charles Ayas, Cancer Medicine	2015	23
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy Hossein Borghaei, Yeun Mi Yim, Annie Guérin, Lung Cancer Palliative CareGeriatric OncologyOncologySevere Adverse EventsElderly Patients	2018	18

Page 1